Hanmi Pharm Co Ltd (128940) — Cash Flow Quality Index
Hanmi Pharm Co Ltd (128940) has a Cash Flow Quality Index of 1.05x as of September 2025. Operating cash flow of ₩42.02 Billion exceeds net income of ₩40.13 Billion, indicating high earnings quality where cash backs reported profits. Explore 128940 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hanmi Pharm Co Ltd Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Hanmi Pharm Co Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hanmi Pharm Co Ltd (128940) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hanmi Pharm Co Ltd (2011–2024)
Year-by-year earnings quality comparison for Hanmi Pharm Co Ltd. For live market cap and the full company financial profile, see 128940 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.56x | ₩193.49 Billion | ₩124.27 Billion | ▲ +14.5% |
| 2023 | 1.36x | ₩216.54 Billion | ₩159.28 Billion | ▼ -35.6% |
| 2022 | 2.11x | ₩162.27 Billion | ₩76.93 Billion | ▼ -15.3% |
| 2021 | 2.49x | ₩201.92 Billion | ₩81.08 Billion | ▼ -80.3% |
| 2020 | 12.67x | ₩151.53 Billion | ₩11.96 Billion | ▲ +5204.9% |
| 2019 | 0.24x | ₩12.45 Billion | ₩52.11 Billion | ▼ -77.1% |
| 2018 | 1.04x | ₩25.98 Billion | ₩24.89 Billion | ▲ +200.3% |
| 2017 | -1.04x | ₩-62.91 Billion | ₩60.43 Billion | ▼ -105.9% |
| 2016 | 17.70x | ₩412.97 Billion | ₩23.33 Billion | ▲ +2588.3% |
| 2015 | 0.66x | ₩101.71 Billion | ₩154.44 Billion | ▲ +171.3% |
| 2014 | -0.92x | ₩-32.82 Billion | ₩35.51 Billion | ▼ -147.2% |
| 2013 | 1.96x | ₩85.99 Billion | ₩43.93 Billion | ▼ -30.0% |
| 2012 | 2.79x | ₩63.27 Billion | ₩22.64 Billion | ▼ -94.1% |
| 2011 | 47.46x | ₩61.30 Billion | ₩1.29 Billion | — |